By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

E. Fougera & Company 

60 Baylis Road

Melville  New York  11747  U.S.A.
Phone: 800-645-9833-Or-631-454-6996 Fax: 631-756-7017


SEARCH JOBS


Industry
Pharmaceutical






Company News
Sandoz Completes Acquisition of Fougera (AAA), Positioning Sandoz as #1 in Generic Dermatology Globally 7/23/2012 9:53:35 AM
Federal Trade Commission OKs Novartis AG (NVS)' $1.5 Billion Fougera (AAA) Buy With Divestitures 7/17/2012 7:29:48 AM
Novartis AG (NVS) Snags Fougera (AAA) for $1.5 Billion for Generic Skin Drugs 5/3/2012 7:38:01 AM
Fougera (AAA) Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin(R) 7/6/2010 12:02:26 PM
Nycomed Announces First Generic Approval of Imiquimod Cream 5% (Rx), Equivalent to Aldara(R) 2/26/2010 6:55:31 AM
FDA Approves Fougera (AAA)'s Clotrimazole Cream USP 1% 9/12/2008 8:30:36 AM
Fougera (AAA) and Protherics PLC Increase DigiFab(R) Digoxin Immune Fab (Ovine) Supply Following Strong Demand 3/19/2008 7:54:00 AM
Fougera (AAA) Receives Approval For First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx) 11/20/2006 9:53:32 AM
Fougera (AAA) First-To-Market With Metronidazole Topical Gel USP 0.75% (Rx) 6/6/2006 12:34:54 PM
Fougera (AAA) First-To-Market With Metronidazole Lotion 0.75% (Rx) 5/24/2006 10:36:38 AM
12
//-->